Moonwalk Biosciences, Inc.
Funding rounds
2 counted as startup funding. Open the number of investors for the round's details.
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
Moonwalk Biosciences, Inc. chose not to state its revenue in its newest notice of a funding round (Sep 2026).
SEC Form D · Sep 2026
The industry group it chose in its notices: Biotechnology.
SEC Form D · Sep 2026
Products and services#
No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).
Investors#
No investor of Moonwalk Biosciences, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| Alexander Aravanis | Executive officer | Sep 2026 |
| Arash Jamshidi | Executive officer | Sep 2026 |
| Elaine Cheung | Executive officer | Sep 2026 |
| John Liles | Executive officer | Sep 2026 |
| Justin Valley | Executive officer | Sep 2026 |
| Stephen Djedjos | Executive officer | Sep 2026 |
| Justin Keller Valley | Executive officer | Jan 2024 |
| Alexander Aravanis | Director | Sep 2026 |
| Arash Jamshidi | Director | Sep 2026 |
| Chris Dimitropoulos | Director | Sep 2026 |
| Paul Burton | Director | Sep 2026 |